The Department of Biomedical Engineering (BME) is committed to investigation, innovation, and translation of scientific discoveries to enhance patient care.
The Department of Biomedical Engineering, formed in 1991 by the amalgamation of the former Departments of Artificial Organs and Musculoskeletal Research, is the largest of eleven highly interactive departments in the Lerner Research Institute of the Cleveland Clinic. The department occupies more than 80,000 sq. ft. (7,500 sq. m.) and consists of more than 200 individuals, approximately 70 of whom hold a Ph.D., M.D., or dual Ph.D.-M.D. degrees. Other department personnel include research engineers and technicians, administrative assistants, manuscript/grant and editorial assistants, a quality control engineer, and more than 40 graduate students.
The department enjoys proven success and has obtained more than $27 million in federal and state grant funding in 2010-2011. It is the leading department in innovation, as determined by the number of invention disclosures filed and patents issued naming BME personnel. Through its close ties with Cleveland Clinic Innovations, BME translates many of its technologies into the clinical arena.
Congratulations to Aimin Wang, PhD, Staff Scientist in the Hascall Laboratory in Biomedical Engineering.
Congratulations to Aimin Wang, PhD, Staff Scientist in the Hascall Laboratory in Biomedical Engineering. His poster, "Bone Marrow Stromal Cells that Divide in Hyperglycemic Medium Initiate Hyaluronan Synthesis Intracellularly and Undergo Pathological Adipogenesis" was one of two posters selected as winners of the 2011 Best Poster Award at Cleveland Clinic's annual Research Day.
Patent Awarded: George Muschler, MD, of Orthopedic Surgery and Biomedical Engineering
Patent Awarded: George Muschler, MD, of Orthopaedic Surgery and Biomedical Engineering was awarded US Patent No. 8,068,670, "Image Analysis of Biological Objects" on November 29, 2011.
10 Feb 2012 | NE1-205 | Biomedical Engineering, "The Cleveland Clinic Growth Map: Opportunities for BME"
Michael Modic, M.D., Institute Chair, Neurological Institute